Stock Analysis Report

Executive Summary

L'Oréal S.A., through its subsidiaries, manufactures and sells cosmetic products for women and men worldwide.


Earnings are forecast to grow 10.87% per year

Pays a high and reliable dividend of 1.58%

Risk Analysis

No risks detected for OR from our risk checks.

Snowflake Analysis

Flawless balance sheet established dividend payer.

Similar Companies

Share Price & News

How has L'Oréal's share price performed over time and what events caused price changes?

Latest Share Price and Events

Stable Share Price: OR has not had significant price volatility in the past 3 months.

Market Performance

7 Day Return




FR Personal Products


FR Market

1 Year Return




FR Personal Products


FR Market

Return vs Industry: OR exceeded the French Personal Products industry which returned 18.6% over the past year.

Return vs Market: OR exceeded the French Market which returned 17% over the past year.

Shareholder returns

7 Day0.4%-1.7%0.4%
30 Day-0.7%-2.6%-0.5%
90 Day6.6%3.5%3.6%
1 Year23.3%21.3%21.7%19.8%20.8%16.7%
3 Year62.6%54.3%62.8%54.4%43.2%29.7%
5 Year86.3%70.8%83.5%68.2%54.8%32.9%

Price Volatility Vs. Market

How volatile is L'Oréal's share price compared to the market and industry in the last 5 years?

Simply Wall St News


Is L'Oréal undervalued compared to its fair value and its price relative to the market?


Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: OR (€268.3) is trading above our estimate of fair value (€225.28)

Significantly Below Fair Value: OR is trading above our estimate of fair value.

Price To Earnings Ratio

PE vs Industry: OR is poor value based on its PE Ratio (40x) compared to the Personal Products industry average (24.1x).

PE vs Market: OR is poor value based on its PE Ratio (40x) compared to the French market (18.7x).

Price to Earnings Growth Ratio

PEG Ratio: OR is poor value based on its PEG Ratio (3.7x)

Price to Book Ratio

PB vs Industry: OR is overvalued based on its PB Ratio (5.1x) compared to the FR Personal Products industry average (2.6x).

Next Steps

Future Growth

How is L'Oréal forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?


Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: OR's forecast earnings growth (10.9% per year) is above the savings rate (-0.1%).

Earnings vs Market: OR's earnings (10.9% per year) are forecast to grow slower than the French market (13.4% per year).

High Growth Earnings: OR's earnings are forecast to grow, but not significantly.

Revenue vs Market: OR's revenue (5.7% per year) is forecast to grow faster than the French market (4.5% per year).

High Growth Revenue: OR's revenue (5.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: OR's Return on Equity is forecast to be low in 3 years time (16%).

Next Steps

Past Performance

How has L'Oréal performed over the past 5 years?


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: OR has high quality earnings.

Growing Profit Margin: OR's current net profit margins (12.6%) are lower than last year (14.5%).

Past Earnings Growth Analysis

Earnings Trend: OR's earnings have grown by 7.4% per year over the past 5 years.

Accelerating Growth: OR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: OR had negative earnings growth (-3.7%) over the past year, making it difficult to compare to the Personal Products industry average (-7.2%).

Return on Equity

High ROE: OR's Return on Equity (12.8%) is considered low.

Return on Assets

Return on Capital Employed

Next Steps

Financial Health

How is L'Oréal's financial position?

Financial Position Analysis

Short Term Liabilities: OR's short term assets (€13.9B) exceed its short term liabilities (€10.9B).

Long Term Liabilities: OR's short term assets (€13.9B) exceed its long term liabilities (€3.5B).

Debt to Equity History and Analysis

Debt Level: OR's debt to equity ratio (2.9%) is considered satisfactory.

Reducing Debt: OR's debt to equity ratio has reduced from 12.7% to 2.9% over the past 5 years.

Debt Coverage: OR's debt is well covered by operating cash flow (736.1%).

Interest Coverage: OR earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet

Inventory Level: OR has a low level of unsold assets or inventory.

Debt Coverage by Assets: OR's debt is covered by short term assets (assets are 16.4x debt).

Next Steps


What is L'Oréal's current dividend yield, its reliability and sustainability?


Current Dividend Yield

Upcoming Dividend Payment

Purchase L'Oréal before the 'Buy Limit' to receive their next dividend payment.

Dividend Yield vs Market


Current dividend yield vs market & industry

Notable Dividend: OR's dividend (1.58%) is higher than the bottom 25% of dividend payers in the French market (1.52%).

High Dividend: OR's dividend (1.58%) is low compared to the top 25% of dividend payers in the French market (4.49%).

Stability and Growth of Payments

Stable Dividend: OR's dividends per share have been stable in the past 10 years.

Growing Dividend: OR's dividend payments have increased over the past 10 years.

Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (63.4%), OR's dividend payments are covered by earnings.

Future Payout to Shareholders

Future Dividend Coverage: OR's dividends in 3 years are forecast to be covered by earnings (55.7% payout ratio).

Next Steps


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Jean-Paul Agon (63yo)





Mr. Jean-Paul Agon has been the Chief Executive Officer of L'Oreal SA since April 25, 2006. Mr. Agon serves as Chief Executive Officer at L'Oreal Australia Pty Ltd. He served as the Chief Executive Officer ...

CEO Compensation Analysis

Compensation vs Market: Jean-Paul's total compensation ($USD10.31M) is above average for companies of similar size in the French market ($USD3.31M).

Compensation vs Earnings: Jean-Paul's compensation has been consistent with company performance over the past year.

Leadership Team

Jean-Paul Agon
Chairman & CEO13.8yrs€9.53m0.19% 283.1m
Christophe Babule
Executive VP & CFO1yrsno datano data
Barbara Lavernos
Executive VP and Chief Technology & Operations Officer5.3yrsno datano data
Françoise Lauvin
Head of Investor Relations0yrsno datano data
Lucia Dumas-Bezian
Executive VP of the Communication & Public Affairs Division2.1yrsno datano data
Jean-Claude Le Grand
Executive Vice President of Human Relations1.6yrsno datano data
Laurent Attal
Executive Vice President of Research & Innovation0yrsno datano data
Jochen Zaumseil
Executive Vice-President of Asia Pacific Zone13.4yrsno datano data
Nicolas Hieronimus
Deputy Chief Executive Officer In Charge of Divisions2.8yrsno datano data
Frédéric Rozé
Executive Vice President of Americas Zone6.6yrsno datano data


Average Tenure


Average Age

Experienced Management: OR's management team is considered experienced (4 years average tenure).

Board Members

Jean-Paul Agon
Chairman & CEO13.8yrs€9.53m0.19% 283.1m
Bernard L. Kasriel
Independent Director15.8yrs€84.00k0.00027% 404.3k
Jean-Pierre Meyers
Vice Chairman26.1yrs€107.00k0.0027% 4.1m
Lindsay Owen-Jones
Honorary Chairman9yrs€11.00kno data
Françoise Meyers
Director22.7yrs€77.50k5.95% 8.9b
Paul Bulcke
Vice-Chairman2.8yrs€107.00k0.00054% 808.6k
Belén Garijo López
Independent Director5.8yrs€78.78k0.00018% 269.5k
Virginie Sarah Morgon
Independent Director6.8yrs€130.00k0.00031% 464.2k
Jean-Victor Meyers
Director8yrs€94.00k0.00027% 404.3k
Sophie Bellon
Independent Director4.8yrs€134.25k0.00019% 284.5k


Average Tenure


Average Age

Experienced Board: OR's board of directors are considered experienced (8.5 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

L'Oréal S.A.'s company bio, employee growth, exchange listings and data sources

Key Information

  • Name: L'Oréal S.A.
  • Ticker: OR
  • Exchange: ENXTPA
  • Founded: 1909
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: €149.747b
  • Shares outstanding: 558.13m
  • Website: https://www.loreal.com

Number of Employees


  • L'Oréal S.A.
  • 41, rue Martre
  • Clichy
  • Ile-de-France
  • 92117
  • France


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
LORADB (Deutsche Boerse AG)ADRDEEURAug 1984
LRLC.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJan 1992
ORENXTPA (Euronext Paris)YesCommon SharesFREURJan 1992
LORDB (Deutsche Boerse AG)YesCommon SharesDEEURJan 1992
0NZMLSE (London Stock Exchange)YesCommon SharesGBEURJan 1992
ORBIT (Borsa Italiana)YesCommon SharesITEURJan 1992
LORXTRA (XETRA Trading Platform)YesCommon SharesDEEURJan 1992
ORPBATS-CHIXE (BATS 'Chi-X Europe')YesCommon SharesGBEURJan 1992
OR NBMV (Bolsa Mexicana de Valores)YesCommon SharesMXMXNJan 1992
ORWBAG (Wiener Boerse AG)YesCommon SharesATEURJan 1992
ORSWX (SIX Swiss Exchange)YesCommon SharesCHCHFJan 1992


L'Oréal S.A., through its subsidiaries, manufactures and sells cosmetic products for women and men worldwide. It operates through four divisions: Consumer Products, L’oréal Luxe, Professional Products, and Active Cosmetics. It offers shampoos, hair care products, shower gels, skin care products, cleansers, hair colors, styling products, deodorants, sun care products, make-up, perfumes, etc. The company provides its products under the L’Oréal Paris, Garnier, Maybelline New York, NYX Professional Makeup Professional Makeup, Essie, Niely, Dark and Lovely, Lancôme, Yves Saint Laurent Beauté, Giorgio Armani Beauty, Kiehl’s, Urban Decay, Biotherm, Ralph Lauren, IT Cosmetics, L'Oréal Professionnel, Kérastase, Redken, Matrix, BIolage, Pureology, Decléor, Carita, Vichy, La Roche-Posay, SkinCeuticals, and Roger&Gallet brands. The company sells its products through distribution channels, such as hair salons, mass-market retail channels, perfumeries, department stores, pharmacies, drugstores, medispas, branded retail, travel retail and e-commerce. The company was founded in 1909 and is headquartered in Clichy, France. 

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/02/19 20:51
End of Day Share Price2020/02/19 00:00
Annual Earnings2019/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.